Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Angela

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
JHEP Reports : Innovation in Hepatology|April 7, 2023
Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trialsClaudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, et al.
The Journal of Prosthetic Dentistry|February 17, 2026
Level of research and scientific interest in immediate dentin sealing: A global bibliometric network analysisMarianella Aguilar Ventura Fadel, Maria Eduarda de Oliveira Castellain, Lucas Menezes Dos Anjos, et al.
Neurology|September 25, 2025
Effects of Phenytoin on the Retinal Ganglion Cell-Inner Plexiform Layer in Acute Optic Neuritis: Analysis of a Phase II Randomized TrialSrikirti Kodali, Alessia Bianchi, Rhian Raftopoulos, et al.
Journal of Applied Oral Science : Revista FOB|May 3, 2023
Dental and composite resin discoloration induced by different hydraulic calcium silicate-based cements: two-year in vitro assessmentLucas Santos de Jesus, Tiago Lopes Dos Santos Reis, Bernardo Guerra Mendonça de Melo Machado, et al.
Journal of Hepatocellular Carcinoma|November 9, 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular CarcinomaGiulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
BMJ Open|September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosisPeter Connick, Floriana De Angelis, Richard A Parker, et al.
The Lancet. Oncology|October 22, 2024
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysisAntonio D'Alessio, Bernardo Stefanini, Julia Blanter, et al.
Cancers|October 28, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and SurvivalKhalil Choucair, Caroline Nebhan, Alessio Cortellini, et al.
The Lancet. Neurology|January 26, 2020
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trialJeremy Chataway, Floriana De Angelis, Peter Connick, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
JHEP Reports : Innovation in Hepatology|April 7, 2023
Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trialsClaudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, et al.
The Journal of Prosthetic Dentistry|February 17, 2026
Level of research and scientific interest in immediate dentin sealing: A global bibliometric network analysisMarianella Aguilar Ventura Fadel, Maria Eduarda de Oliveira Castellain, Lucas Menezes Dos Anjos, et al.
Neurology|September 25, 2025
Effects of Phenytoin on the Retinal Ganglion Cell-Inner Plexiform Layer in Acute Optic Neuritis: Analysis of a Phase II Randomized TrialSrikirti Kodali, Alessia Bianchi, Rhian Raftopoulos, et al.
Journal of Applied Oral Science : Revista FOB|May 3, 2023
Dental and composite resin discoloration induced by different hydraulic calcium silicate-based cements: two-year in vitro assessmentLucas Santos de Jesus, Tiago Lopes Dos Santos Reis, Bernardo Guerra Mendonça de Melo Machado, et al.
Journal of Hepatocellular Carcinoma|November 9, 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular CarcinomaGiulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
BMJ Open|September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosisPeter Connick, Floriana De Angelis, Richard A Parker, et al.
The Lancet. Oncology|October 22, 2024
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysisAntonio D'Alessio, Bernardo Stefanini, Julia Blanter, et al.
Cancers|October 28, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and SurvivalKhalil Choucair, Caroline Nebhan, Alessio Cortellini, et al.
The Lancet. Neurology|January 26, 2020
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trialJeremy Chataway, Floriana De Angelis, Peter Connick, et al.
Pageof 7